Misuse of Drugs Act 1971 (Temporary Class Drug) Order 2026
House of Commons · General Committees · 7 Jul 2026 · 31 speeches · Official Report
The Committee consisted of the following Members:
Chair: Martin Vickers
† Blackman, Bob (Harrow East) (Con)
† Botterill, Jade (Lord Commissioner of His Majesty's Treasury)
† Brown-Fuller, Jess (Chichester) (LD)
† Crichton, Torcuil (Na h-Eileanan an Iar) (Lab)
† Fahnbulleh, Miatta (Peckham) (Lab/Co-op)
† Foxcroft, Vicky (Lewisham North) (Lab)
Goldman, Marie (Chelmsford) (LD)
† Griffith, Dame Nia (Llanelli) (Lab)
† Jones, Lillian (Kilmarnock and Loudoun) (Lab)
† Jones, Sarah (Minister for Policing and Crime)
† Lam, Katie (Weald of Kent) (Con)
† Lavery, Ian (Blyth and Ashington) (Lab)
† McKinnell, Catherine (Newcastle upon Tyne North) (Lab)
† Paffey, Darren (Southampton Itchen) (Lab)
† Stephenson, Blake (Mid Bedfordshire) (Con)
† Thompson, Adam (Erewash) (Lab)
† Vickers, Matt (Stockton West) (Con)
Claire Cozens, Committee Clerk
† attended the Committee
Second Delegated Legislation Committee
Tuesday 7 July 2026
[Martin Vickers in the Chair ]
Misuse of Drugs Act 1971 (Temporary Class Drug) Order 2026
I beg to move, That the Committee has considered the Misuse of Drugs Act 1971 (Temporary Class Drug) Order 2026 (S.I., 2026, No. 613). It is a pleasure to serve under your chairmanship, Mr Vickers. The statutory instrument, which was laid before Parliament on 10 June, places controls on a new, highly lethal class of drug. Orphines are a type of synthetic opioid, which emerged in force in the UK drugs market last spring. In that time, they have been involved in at least 22 deaths, 14 of which were between December and March. Between 2024 and April 2026, the United Nations Office on Drugs and Crime received 206 reports from multiple countries of drug samples containing orphine compounds. The report of 30 April from the Advisory Council on the Misuse of Drugs, for which I am very grateful, stated that, “the risk to the population from these recently emerging compounds is sufficiently great that urgent steps are required to protect public health.” We have taken those urgent steps. Less than six weeks after the report was published, we enacted a temporary class drug order-the first in a decade-to control seven orphines. I will spare Committee members the complex chemical names, but they are all set out in the order and the explanatory memorandum. I confirm that three of the seven have been involved in UK deaths, and the European Union drugs agency has notified that the other four are present in the EU drugs market. The TCDO makes it a specific offence to produce, supply or offer...
Thank you, Mr Vickers, for chairing today’s debate. For the avoidance of doubt, I want to be clear that the Opposition support the Government’s decision, and welcome what I hope is a first step to stop the proliferation of these dangerous substances. The evidence that the Government and our international partners have presented on orphines shows them to be dangerous substances that we must stop being used as quickly as possible. We must act expediently to crack down on new and dangerous substances without medical uses and stop them making their way into our society. Orphines have already been involved in at least 15 deaths since spring 2025, and I share the concerns of both the Government and the ACMD about the urgent steps needed to protect public health. In that light, the important question for the Government is: when do they expect to transition from the temporary order to a permanent measure that will offer enhanced powers to stop their use? We all recognise that a transition in leadership can cause difficulties in Ministers offering assurances, but it would be helpful if they could set out a timeline for when we might expect the change to be made. Recognising the dangers posed by this compound, we must also acknowledge the need to be agile and have robust enforcement. A presentation by the Australian Prompt Response Network in June this year, on the emerging threat of new synthetic orphines, identified 14 analogues. Although the three most frequently identified on the...
To follow on from the point made by the shadow Minister, the hon. Member for Stockton West, the ACMD recommends that orphines should be classed as class A, whereas under a temporary class drug order, they can be placed only within class B boundaries. My understanding is that the Minister has accepted the recommendation to bring them into line with class A. Does she recognise that it is important to introduce the permanent controls as quickly as possible?
I have a few questions for the Minister. These are extremely harmful drugs that threaten the people who take them. Can the Minister update the Committee on whether they are arriving in the country in their final form or whether they are synthesised in this country from raw products, and how are they being administered right now? It is clearly important for enforcement to know whether we need to stop them at the point of entry or whether we need to take action in the community to identify the drugs and seize them. Can the Minister update us on whether the ingredients of these harmful drugs can be brought in legally but then synthesised in this country? That will have an effect on enforcement as well. Finally, have the police established the prevalence of these products? I completely accept the number of deaths that have been caused, but equally, the drugs might be being used in a more widespread way.
I thank hon. Members for their points and for welcoming the changes that we are making. As I explained, we have accepted that orphines should be classed as class A, but there is a different parliamentary process through which we will make them class A. We will do that as quickly as possible. The shadow Minister, the hon. Member for Stockton West, asked when it will happen. I cannot give a specific date, but two things are true. First, we will do it as soon as possible, and secondly, the order lasts for only a year, so we will have to do it within that time anyway. We will ensure that we do it well within that time. It is the right thing to do, and we have accepted what the ACMD has suggested. When we introduce the legislation to make orphines class A, we can use a more generic definition. The shadow Minister made a point about different forms of these substances, and the generic definition will help us to cover more substances as they get made. He is right to say that as we pick up and act on certain new synthetic opioids, new ones pop up along the way. The hon. Member for Harrow East asked where the drugs are coming from and how they are presenting themselves. There is a risk of them being made in this country and coming from abroad, but they are mainly coming from abroad. I think there have been two cases where nitazenes-similar substances-have been found being produced in Scotland. I will write to the hon. Gentleman if I have the wrong drug type, but there are two cases...
Committee rose.